Why Shares in UPS Declined by 20% in the First Half of 2025

United Parcel Service (UPS) shares declined 20% in the first half of 2025 as investors express concern over the company's ability to meet its full-year guidance, primarily due to weaker delivery volumes stemming from ongoing trade tariff disputes. This pressure on earnings and projected Free Cash Flow (FCF) of $5.7 billion, which barely covers planned dividends and buybacks, suggests a potential dividend cut. While typically negative, the article posits that a dividend reduction could be a positive for investors if the freed capital is strategically reinvested into high-growth areas like healthcare and small-to-medium businesses. Investors are now keenly awaiting the Q2 earnings report in late July for an updated guidance.

Analysis

United Parcel Service (UPS) shares experienced a significant 20% decline in the first half of 2025, driven by mounting investor concerns over the company's ability to achieve its full-year guidance. Management's initial forecast of $89 billion in revenue and a 10.8% operating margin is under pressure from weaker-than-expected delivery volumes, which the article attributes to ongoing trade tariff disputes. This situation is amplified by UPS's recent history of missing its initial guidance in both 2023 and 2024. A critical point of stress is the company's capital allocation plan; the projected $5.7 billion in free cash flow (FCF) is insufficient to cover the combined $6.5 billion commitment to dividends ($5.5 billion) and share buybacks ($1 billion). While a dividend cut would negatively impact income-focused investors drawn to the current 6.5% yield, the article posits it could be a strategic positive, enabling reinvestment into high-growth areas like healthcare and small-to-medium business services. The lack of an updated forecast in the first-quarter earnings report has heightened uncertainty, making the upcoming second-quarter results in late July a pivotal event for clarity on both earnings and capital strategy.

Key Decisions for Investors

• Investors should closely monitor the late July second-quarter earnings report for any revision to full-year guidance, as this will be a key catalyst for the stock's direction.
• Given that projected free cash flow of $5.7 billion does not cover the planned $6.5 billion in dividends and buybacks, a dividend cut is a distinct possibility; income-oriented investors should assess their exposure to this risk.
• Consider that a dividend reduction, while negative for near-term sentiment, could be re-framed as a long-term positive if management provides a clear strategy for reinvesting the capital into its identified growth initiatives in healthcare and SMBs.
• The current negative sentiment and 20% share price decline reflect significant uncertainty, so any new positions should be weighed against the binary risk of a potential guidance miss versus a rebound on positive news.